BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18523390)

  • 1. Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E2.
    Namazi MR
    Dermatology; 2008; 217(2):149. PubMed ID: 18523390
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):2011; author reply 2011. PubMed ID: 16380801
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
    Chiu SH; Liu IL; Chen YW; Lan CE
    J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultraviolet A in vitiligo.
    El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
    De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
    Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Ultraviolet Light on Vitiligo.
    Singh RK
    Adv Exp Med Biol; 2017; 996():55-60. PubMed ID: 29124690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo.
    Ganzetti G; Simonetti O; Campanati A; Giuliodori K; Offidani A
    Acta Derm Venereol; 2010 Nov; 90(6):642-3. PubMed ID: 21057754
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial and molecular study of photoadaptation in vitiligo.
    Hexsel CL; Mahmoud BH; Mitchell D; Rivard J; Owen M; Strickland FM; Lim HW; Hamzavi I
    Br J Dermatol; 2009 Mar; 160(3):534-9. PubMed ID: 19067714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of narrowband ultraviolet B on hypertrophic scar in a patient having an isomorphic phenomenon and vitiligo.
    Oiso N; Kawara S; Kawada A
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1003-4. PubMed ID: 19522915
    [No Abstract]   [Full Text] [Related]  

  • 15. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren's syndrome.
    Tanioka M; Takahashi K; Miyachi YI
    Clin Exp Dermatol; 2009 Apr; 34(3):418-20. PubMed ID: 19120387
    [No Abstract]   [Full Text] [Related]  

  • 16. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study.
    Wind BS; Kroon MW; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Meesters AA; Bos JD; Wolkerstorfer A
    Br J Dermatol; 2010 May; 162(5):1142-4. PubMed ID: 20199553
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 18. Narrow-band ultraviolet B comb as an effective home-based phototherapy device for limited or localized non-segmental vitiligo: A pilot, open-label, single-arm clinical study.
    Khandpur S; Bhatia R; Bhadoria AS
    Indian J Dermatol Venereol Leprol; 2020; 86(3):298-301. PubMed ID: 32068191
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted UV therapy in the treatment of psoriasis.
    Stein KR; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2008; 19(3):141-5. PubMed ID: 17934935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylalanine and UVA for Vitiligo patients: probability of an effective treatment.
    Reuss S; Weiss C; Bayerl C
    Med Hypotheses; 2006; 67(1):199-200. PubMed ID: 16554122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.